TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss

TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss

Abstract Background To investigate the effect of TriBAFF-CAR-T cells on hematological tumor cells. Methods TriBAFF-CAR-T and CD19-CAR-T cells were co-cultured with BAFFR-bearing B-cell malignancies at different effector/target ratios to evaluate the anti-tumor effects. In vivo, TriBAFF-CAR-T and CD1...

Full description

Bibliographic Details
Main Authors: Guangchao Li, Qing Zhang, Zhi Liu, Huijuan Shen, Yangmin Zhu, Zhao Zhou, Wen Ding, Siqi Han, Jie Zhou, Ruiming Ou, Min Luo, Shuang Liu
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Cancer Cell International
Subjects:
BAFF
Trimer
CAR-T
Hematological tumor
Tumor relapse
Online Access:https://doi.org/10.1186/s12935-021-01923-x

Internet

https://doi.org/10.1186/s12935-021-01923-x

Similar Items